Early Chronic Obstructive Pulmonary Disease or Early Detection of Mild Disease?
Early Chronic Obstructive Pulmonary Disease or Early Detection of Mild Disease?
复制标题
早期慢性阻塞性肺疾病或早期发现轻度疾病?
DOI:
10.1164/rccm.201802-0257le
复制
发表时间:
2018
影响因子:
24.7
通讯作者:
Bhatt,SuryaP
中科院分区:
文献类型:
--
作者:
Bhatt,SuryaP
The Perspective article by Martinez and colleagues on differentiating early chronic obstructive pulmonary disease (COPD) from mild disease is an excellent and timely discourse on this important topic (1). Mild and early airflow obstruction are frequently conflated by both clinicians and researchers. Mild disease, when observed, is hard to differentiate from early disease, and the only differentiator is temporal information. The authors propose a number of criteria to attempt differentiation of early and mild disease. Although these suggestions are practical, there are some issues with adapting the “required” criteria for clinical or research purposes. The recommendation that persons younger than 50 years of age should be considered to have early disease does not have a temporal component and does not take into consideration that a majority of smokers start smoking in their teens and hence would have already accumulated a substantial number of pack-years of smoking burden by the time they are in their forties. We recently showed that the duration of smoking is more strongly associated with measures of COPD than the composite index of pack-years (2). It is easy to ascertain the onset of smoking, and so a temporal component can be easily included by terming those with airflow obstruction within a conservative 10 years of smoking onset as having early COPD. For non–smoking-related COPD, temporality is harder to establish, but a lower age threshold may help. Furthermore, a few other suggestions need clarification. First, the authors recommend using post-bronchodilator values for the lower limit of normal (LLN). Unfortunately, available LLN values are prebronchodilator. This is not a trivial issue; Tilert and colleagues showed that using post-bronchodilator fixed ratio less than 0.70 and prebronchodilator ratio less than LLN provide similar population estimates of airflow obstruction, whereas applying prebronchodilator criteria to post-bronchodilator tests results in prevalence estimates that are two-thirds of those obtained using prebronchodilator tests (3). Thus, post-bronchodilator LLN is likely to be more specific, but this may result in missing early cases of airflow obstruction for which sensitivity may be more important. Second, computed tomography can identify alteration in the lung parenchyma and airways before detection of airflow obstruction, but most smokers are likely to have some structural changes, and